AVROBIO, INC. Overview
Company Headquarters: Cambridge, US
Founded: 2003
Workforce: ~51–200
Company Working: AVROBIO, Inc. (AVROBIO) is a phase two clinical-stage gene therapy company. The company’s Plato platform includes a proprietary vector system, automated cell manufacturing solution, and refined conditioning regimen with therapeutic drug monitoring. AVROBIO is headquartered in Cambridge, US, and has offices in Toronto.
Strategy
AVROBIO is focused on developing gene therapy treatment for rare diseases such as Fabry disease and Pompe disease. It also focuses on gene therapy programs in other lysosomal storage disorders, including Gaucher disease and cystinosis. The company intends to build a global infrastructure to provide treatment to patients around the world.
